Mathematical Analysis of Signals and Clinical Parameters Provided by Non-invasive Home Ventilation Devices

Recruiting Observational Study
COPD (Chronic Obstructive Pulmonary Disease)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 80
Sex
Any
Study type
Observational
Participants needed
75 (estimated)
Sponsor
Corporacion Parc Tauli · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will look at people with COPD who use a home breathing machine called non-invasive ventilation (NIV). NIV machines collect information about your breathing, such as air flow, pressure, and mask leaks. Researchers want to use a computer program, called artificial intelligence (AI), to study this information. The goal is to find early signs that your breathing may be getting worse. Peop…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age between 40 and 80 years. * COPD diagnosed by pulmonary function tests. * Home NIV therapy with good adherence (minimum daily compliance \> 5 hours) for at least 6 months. * Users of the ResMed LUMIS 150 ventilator. This is due to the presence of the decoding tool and a lar…
Contacts

Manel Lujan, Professor MD pHD

+34 937231010

mlujan@tauli.cat

CONTACT

Cristina Lalmolda Puyol, RT phD

+34 692186820

clalmolda@tauli.cat

CONTACT